XPO, Inc.
$25.71B- Market cap
- $22.61B
- Debt
- +$3.41B
- Cash
- −$310.00M
Capital structure 87% equity / 13% debt · EV / Revenue 3.15x · EV / EBITDA 35.51x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $22.61B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: XPO stock price at premium vs KRYS $193.10 current versus $138.27 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at KRYS's multiple
Implied fair value · at XPO's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Expensive
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: XPO FY 2025 (ended Dec 31, 2025) · KRYS FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 87% equity / 13% debt · EV / Revenue 3.15x · EV / EBITDA 35.51x
Capital structure 99% equity / 1% debt · EV / Revenue 26.18x · EV / EBITDA 51.97x
XPO carries the larger enterprise value at $25.71B against $10.19B; XPO trades on the lower EV / Revenue multiple (3.15x vs 26.18x); XPO on the lower EV / EBITDA (35.51x vs 51.97x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
XPO, Inc. · implied price per share
Bear
-$17.35
Base
-$15.65
Bull
-$13.36
Krystal Biotech, Inc. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.83x
0.07x
Net debt / EBITDA
Leverage against operating earnings
4.28x
-2.13x
Cash and equivalents
Liquid reserves on the balance sheet
$310.00M
$496.30M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
C. H. ROBINSON WORLDWIDE, INC.
XPO vs CHRW
Hub Group, Inc.
XPO vs HUBG
SAIA INC
XPO vs SAIA
OLD DOMINION FREIGHT LINE, INC.
XPO vs ODFL
FEDEX CORP
XPO vs FDX
UNITED PARCEL SERVICE INC
XPO vs UPS
uniQure N.V.
XPO vs QURE
Sarepta Therapeutics, Inc.
XPO vs SRPT
REGENXBIO Inc.
XPO vs RGNX
Ultragenyx Pharmaceutical Inc.
XPO vs RARE
$3.41B
$79.46M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.